Deutsche Bank Ag\ Aeglea Bio Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.5 - $2.66 $257,566 - $1.37 Million	-515,133 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.87 - $4.77 $917,418 - $2.34 Million	490,598 Added 1999.58%	515,133 $1.19 Million
Q4 2021 Feb 11, 2022	BUY	$3.5 - $8.42 $4,522 - $10,878	1,292 Added 5.56%	24,535 $117,000
Q3 2021 Nov 04, 2021	SELL	$6.03 - $7.95 $4,522 - $5,962	-750 Reduced 3.13%	23,243 $185,000
Q2 2021 Aug 11, 2021	SELL	$6.32 - $8.38 $42,502 - $56,355	-6,725 Reduced 21.89%	23,993 $167,000
Q1 2021 May 13, 2021	SELL	$6.76 - $8.57 $18,556 - $23,524	-2,745 Reduced 8.2%	30,718 $243,000
Q4 2020 Feb 16, 2021	SELL	$7.02 - $9.83 $225,313 - $315,503	-32,096 Reduced 48.96%	33,463 $263,000
Q3 2020 Nov 12, 2020	BUY	$6.51 - $9.33 $13,254 - $18,995	2,036 Added 3.21%	65,559 $465,000
Q2 2020 Aug 13, 2020	BUY	$4.01 - $11.04 $50,205 - $138,220	12,520 Added 24.55%	63,523 $588,000
Q1 2020 May 14, 2020	SELL	$3.51 - $8.48 $44,808 - $108,255	-12,766 Reduced 20.02%	51,003 $238,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $8.55 $410,121 - $484,998	56,725 Added 805.3%	63,769 $486,000
Q3 2019 Nov 14, 2019	SELL	$6.42 - $9.0 $63,545 - $89,082	-9,898 Reduced 58.42%	7,044 $53,000
Q2 2019 Aug 14, 2019	SELL	$6.1 - $8.78 $36,008 - $51,828	-5,903 Reduced 25.84%	16,942 $115,000
Q1 2019 May 15, 2019	BUY	$7.6 - $9.4 $27,671 - $34,225	3,641 Added 18.96%	22,845 $183,000
Q4 2018 Feb 14, 2019	SELL	$6.51 - $10.19 $117,277 - $183,572	-18,015 Reduced 48.4%	19,204 $143,000
Q3 2018 Dec 21, 2021	BUY	$8.24 - $11.0 $35,399 - $47,256	4,296 Added 13.05%	37,219 $356,000
Q3 2018 Nov 14, 2018	SELL	$8.24 - $11.0 $1.26 Million - $1.68 Million	-152,571 Reduced 82.25%	32,923 $313,000
Q2 2018 Apr 21, 2020	BUY	$7.87 - $10.89 $41,640 - $57,618	5,291 Added 2.94%	185,494 $1.96 Million
Q2 2018 Aug 14, 2018	BUY	$7.87 - $10.89 $1.42 Million - $1.96 Million	180,203 New	180,203 $1.91 Million

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account